HIV-1 diversity and the implementation of integrase strand-transfer inhibitors as part of combination antiretroviral therapy

S G Mikasi; G M Ikomey; A E Obasa; R Cloete; G B Jacobs

doi:10.7196/SAMJ.2020.v110i9.14848

Correspondence

HIV-1 diversity and the implementation of integrase strand-transfer inhibitors as part of combination antiretroviral therapy

S G Mikasi, G M Ikomey, A E Obasa, R Cloete, G B Jacobs

Authors' affiliations

S G Mikasi, Division of Medical Virology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

G M Ikomey, Centre for the Study and Control of Communicable Diseases, University of Yaoundé 1, Cameroon

A E Obasa, Division of Medical Virology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

R Cloete, South African Medical Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa

G B Jacobs, Division of Medical Virology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa